Immune Landscape of Pancreatic Cancer Development and Drug Resistance: Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, cartea 5
Editat de Batoul Farran, Ganji Purnachandra Nagarajuen Limba Engleză Hardback – 14 iun 2024
This book is a valuable resource for health professionals, scientists and researchers, students, and all those who wish to broaden their knowledge of advances in immunotherapy in pancreatic cancer.
- Summarizes the potential combination strategies and latest clinical trials in pancreatic cancer
- Provides an in-depth overview of our current understanding of pancreatic cancer development, including its mutational and immune features
- Explores some of the new immune-based therapies aimed at targeting PC
- Shows pancreatic cancer progression and basic elements in tumor microenvironments and their role in PC progression, also covering immunotherapy strategies
Preț: 830.54 lei
Preț vechi: 1084.90 lei
-23% Nou
Puncte Express: 1246
Preț estimativ în valută:
158.94€ • 164.93$ • 132.85£
158.94€ • 164.93$ • 132.85£
Carte tipărită la comandă
Livrare economică 10-24 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443235238
ISBN-10: 0443235236
Pagini: 312
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Seria Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy
ISBN-10: 0443235236
Pagini: 312
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Seria Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy
Cuprins
1. Introduction
2. Molecular profiling and mutational landscape of pancreatic cancer
3. Tumor microenvironment and immune components interaction in pancreatic ductal adenocarcinoma
4. Identification of immune targeted molecules in pancreatic ductal adenocarcinoma
5. Targeting macrophages for pancreatic cancer therapy
6. Targeting cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
7. Targeting short-lived immunosuppressive myeloid cells for PDAC therapy
8. Targeting T-regs in PDAC
9. Immune-modulators for PDAC therapy
10. Current clinical trials in PDAC immunotherapy
11. Precision medicine in PDAC immunotherapy
12. Artificial intelligence in pancreatic cancer immunotherapy
2. Molecular profiling and mutational landscape of pancreatic cancer
3. Tumor microenvironment and immune components interaction in pancreatic ductal adenocarcinoma
4. Identification of immune targeted molecules in pancreatic ductal adenocarcinoma
5. Targeting macrophages for pancreatic cancer therapy
6. Targeting cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
7. Targeting short-lived immunosuppressive myeloid cells for PDAC therapy
8. Targeting T-regs in PDAC
9. Immune-modulators for PDAC therapy
10. Current clinical trials in PDAC immunotherapy
11. Precision medicine in PDAC immunotherapy
12. Artificial intelligence in pancreatic cancer immunotherapy